Nephrology (10-15%) Complete Flashcards by robin jindal

Q

Measuring BP

A

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

HTN Diagnosis algorithm

A

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

Hypertension:
– If NO nocturnal dip (sufficient dip >10% drop ) —> associated with increased risk of ___________________

A

– If NO nocturnal dip (sufficient dip >10% drop ) —> associated with increased risk of CV events

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

• All patients being treated for HTN should be monitored for new appearance of ________________ (as per CDA guidelines)

A

• All patients being treated for HTN should be monitored for new appearance of DM (as per CDA guidelines)

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

In Htn: ___________ is recommended with ≥3 risk factors of CVD or with established atherosclerotic disease, regardless of age

A

In Htn: Statin therapy is recommended with ≥3 risk factors of CVD or with established atherosclerotic disease, regardless of age

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

Secondary HTN causes

A

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

Hyperaldosteronism

A

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

HTN 2020 – Renovascular HTN

A

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

FMD related renal artery stenosis

A

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

Hypertension Goals

A

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

High risk patient (“SPRINT” trial Candidates)

A

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

HTN: Treatment: Lifestyle

A

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

HTN: First-Line Therapy

A

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

Diabetes and HTN

A

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

Renovascular HTN

A

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

HTNN: Other Special Populations - 1

A

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

Other Special Populations - 2

A

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

Other Special Populations - 3

A

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

HTNN: Response to Therapy

A

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

Interpreting urine microscopy

A

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

Anti-GBM disease

A

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

Pauci-immune / ANCA Vasculitis

A

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

Pauci-immune / ANCA Vasculitis

A

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

Immune complex: Low C3

A

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

Immune complex: Low C4*

A

How well did you know this?

1

Not at all

2

3

4

5

Perfectly

Q

Immune complex: Low C3/C4

A

Q

Immune Complex: Normal C3/C4

A

Q

IgA Nephropathy treatment

A

Q

Nephrotic syndrome

A

Q

Management of Nephrotic Syndrome

A

Q

Acute interstitial nephritis [AIN]

A

Q

Contrast-Induced Nephropathy
Cholesterol emboli syndrome

A

Q

Rhabdomyolysis

A

Q

Hepatorenal syndrome

A

Q

Causes of AKI in transplant

A

Q

Prevent progression: CKD Targets

A

Q

Statins in ESRD

A

Q

Sick Day Management

A

Q

CKD: Management of Complications

A

Q

CKD: Management of Complications
Anemia

A

Q

CKD - MBD: Management of Complications

A

Q

CKD: Management of Complications

A

Q

CKD: Management of Complications

A

Q

CKD: Management of Complications

A

Q

Uremic Symptoms on History

A

Q

Indications for Dialysis

A

Q

CKD and Diabetes

A

Q

CKD and Diabetes: Pharmacotherapy in 2022/2023:
First Line?

A

Q

KDIGO DM/CKD 2022 pharmacotherapy guidelines

A

Q

Metabolic Acidosis

A

Q

Causes of AGMA

A

Q

Causes of Increased Osmolar Gap

A

Q

RTA

A

Q

Hyponatremia correction formula:

A

Q

Hyponatremia: Risk factors for demyelination?

A

Q

Pseudohyponatremia

A

Q

Hyponatremia

A

Q

Free Water Deficit Formula

A

Q

Nephrogenic DI:
Associated with?

A

Q

Hyperkalemia

A

Q

Chronic hypokalemia

A

Q

Kidney biopsy

A

Q

Nephrolithiasis

A